KOZARICH JOHN W — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

KOZARICH JOHN W has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.18M.

Profile

KOZARICH JOHN W

John W. Kozarich is a corporate director known for his role at Ligand Pharmaceuticals Inc., where he has served as a director. He has participated in multiple SEC filings, indicating his involvement in the company's governance.

RoleDirector
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-09LGNDLIGAND PHARMACEUTICALS INCA — Grant or award836$0.00
2026-05-15LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale1.6K$223.50$352K
2026-05-15LGNDLIGAND PHARMACEUTICALS INCM — Option exercise1.6K$69.51$109K
2026-05-15LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale459$224.00$103K
2026-05-15LGNDLIGAND PHARMACEUTICALS INCM — Option exercise459$69.51$32K
2026-05-15LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale116$234.09$27K
2026-05-15LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale105$232.57$24K
2026-05-15LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale165$231.87$38K
2026-05-15LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale1$229.87$230
2026-05-15LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale80$227.37$18K
2026-04-02LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]159$204.26$32K
2026-04-02LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]43$202.91$9K
2026-04-02LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]79$202.42$16K
2026-04-02LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]40$201.24$8K
2026-04-02LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]146$199.97$29K
2026-03-05LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]42$203.57$9K
2026-03-05LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]50$202.54$10K
2026-03-05LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]83$201.65$17K
2026-03-05LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]41$200.40$8K
2026-03-05LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]204$199.69$41K

Companies — Last 90 Days

Frequently Asked Questions

Who is KOZARICH JOHN W?

John W. Kozarich is a corporate director known for his role at Ligand Pharmaceuticals Inc., where he has served as a director. He has participated in multiple SEC filings, indicating his involvement in the company's governance.…

How many SEC Form 4 filings has KOZARICH JOHN W submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has KOZARICH JOHN W been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 32 open-market sales ($1.18M) across all tracked filings.

Where can I see all of KOZARICH JOHN W's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live KOZARICH JOHN W profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.